{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260611005104/en/Silence-Therapeutics-Highlights-Follow-Up-Data-at-EHA-2026-Demonstrating-Durable-Efficacy-and-Potential-Best-in-Class-Profile-for-Divesiran-in-Polycythemia-Vera", "message": "News view counter 793097 successfully enlarged"}